wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26767180-3120BA88-FC6F-4B3B-B261-6AF61AF5B17F
Q26767180-3120BA88-FC6F-4B3B-B261-6AF61AF5B17F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26767180-3120BA88-FC6F-4B3B-B261-6AF61AF5B17F
Position statement for the use of omalizumab in the management of chronic spontaneous urticaria in Indian patients
P2860
Q26767180-3120BA88-FC6F-4B3B-B261-6AF61AF5B17F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26767180-3120BA88-FC6F-4B3B-B261-6AF61AF5B17F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
890ba9149769312a885ba3eef374f689e2794da7
P2860
Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.